Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2008

Open Access 01-12-2008 | Original investigation

Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice

Authors: Riikka Kivelä, Mika Silvennoinen, Maarit Lehti, Sanni Jalava, Veikko Vihko, Heikki Kainulainen

Published in: Cardiovascular Diabetology | Issue 1/2008

Login to get access

Abstract

Background

Diabetes has negative, and exercise training positive, effects on the skeletal muscle vasculature, but the mechanisms are not yet fully understood. In the present experiment the effects of running exercise on the mRNA expression of pro- and antiangiogenic factors were studied in healthy and diabetic skeletal muscle. The responses in capillaries and muscle fibers, collected from the muscle with laser capture microdissection, were also studied separately.

Methods

Healthy and streptozotocin-induced diabetic mice were divided into sedentary and exercise groups. Exercise was a single bout of 1 h running on a treadmill. Gastrocnemius muscles were harvested 3 h and 6 h post exercise, and angiogenesis-related gene expressions were analyzed with real-time PCR. In addition to muscle homogenates, capillaries and muscle fibers were collected from the muscle with laser capture microdissection method and analyzed for vascular endothelial growth factor-A (VEGF-A) and thrombospondin-1 (TSP-1) mRNA expression.

Results

Of the proangiogenic factors, VEGF-A and VEGF receptor-2 (VEGFR-2) mRNA expression increased significantly (P < 0.05) in healthy skeletal muscle 6 h post exercise. VEGF-B also showed a similar trend (P = 0.08). No significant change was observed post exercise in diabetic muscles in the expression of VEGF-A, VEGFR-2 or VEGF-B. The expression of angiogenesis inhibitor TSP-1 and angiogenic extracellular matrix protein Cyr61 were significantly increased in diabetic muscles (P < 0.05–0.01). Capillary mRNA expression resembled that in the muscle homogenates, however, the responses were greater in capillaries compared to muscle homogenates and pure muscle fibers.

Conclusion

The present study is the first to report the effects of a single bout of exercise on the expression of pro- and antiangiogenic factors in diabetic skeletal muscle, and it provides novel data about the separate responses in capillaries and muscle fibers to exercise and diabetes. Diabetic mice seem to have lower angiogenic responses to exercise compared to healthy mice, and they show markedly increased expression of angiogenesis inhibitor TSP-1. Furthermore, exercise-induced VEGF-A expression was shown to be greater in capillaries than in muscle fibers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tamarat R, Silvestre JS, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, Wautier MP, Wautier JL, Levy BI: Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA. 2003, 100: 8555-8560. 10.1073/pnas.1236929100.PubMedCentralCrossRefPubMed Tamarat R, Silvestre JS, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, Wautier MP, Wautier JL, Levy BI: Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci USA. 2003, 100: 8555-8560. 10.1073/pnas.1236929100.PubMedCentralCrossRefPubMed
2.
go back to reference Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM: Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol. 1999, 154: 355-363.PubMedCentralCrossRefPubMed Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM: Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol. 1999, 154: 355-363.PubMedCentralCrossRefPubMed
3.
go back to reference Carmeliet P: Angiogenesis in life, disease and medicine. Nature. 2005, 438: 932-936. 10.1038/nature04478.CrossRefPubMed Carmeliet P: Angiogenesis in life, disease and medicine. Nature. 2005, 438: 932-936. 10.1038/nature04478.CrossRefPubMed
4.
go back to reference Kivelä R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H, Vihko V: Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 2006, 20: 1570-1572. 10.1096/fj.05-4780fje.CrossRefPubMed Kivelä R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H, Vihko V: Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 2006, 20: 1570-1572. 10.1096/fj.05-4780fje.CrossRefPubMed
5.
go back to reference Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K: Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol. 2005, 25: 1603-1609. 10.1161/01.ATV.0000171994.89106.ca.CrossRefPubMed Schiekofer S, Galasso G, Sato K, Kraus BJ, Walsh K: Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol. 2005, 25: 1603-1609. 10.1161/01.ATV.0000171994.89106.ca.CrossRefPubMed
6.
go back to reference Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992, 72: 369-417.PubMed Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev. 1992, 72: 369-417.PubMed
7.
go back to reference Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999, 99: 2239-2242.CrossRefPubMed Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999, 99: 2239-2242.CrossRefPubMed
8.
go back to reference Tanii M, Yonemitsu Y, Fujii T, Shikada Y, Kohno R, Onimaru M, Okano S, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K: Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res. 2006, 98: 55-62. 10.1161/01.RES.0000197842.38758.45.CrossRefPubMed Tanii M, Yonemitsu Y, Fujii T, Shikada Y, Kohno R, Onimaru M, Okano S, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K: Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res. 2006, 98: 55-62. 10.1161/01.RES.0000197842.38758.45.CrossRefPubMed
9.
go back to reference Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y: Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes. 2006, 55: 2245-2255. 10.2337/db05-1375.CrossRefPubMed Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y: Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes. 2006, 55: 2245-2255. 10.2337/db05-1375.CrossRefPubMed
10.
go back to reference Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH: In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes. 2007, 56: 656-665. 10.2337/db06-0999.CrossRefPubMed Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH: In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes. 2007, 56: 656-665. 10.2337/db06-0999.CrossRefPubMed
11.
go back to reference Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, Clements RT, Sellke FW: Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007, 116: I31-7. 10.1161/CIRCULATIONAHA.106.680157.PubMedCentralCrossRefPubMed Boodhwani M, Sodha NR, Mieno S, Xu SH, Feng J, Ramlawi B, Clements RT, Sellke FW: Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007, 116: I31-7. 10.1161/CIRCULATIONAHA.106.680157.PubMedCentralCrossRefPubMed
12.
go back to reference Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH: Impaired Angiogenesis Following Hindlimb Ischemia in Type 2 Diabetes Mellitus. Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble VEGFR-1. Circ Res. 2007, 101: 948-956. 10.1161/CIRCRESAHA.107.160630.CrossRefPubMed Hazarika S, Dokun AO, Li Y, Popel AS, Kontos CD, Annex BH: Impaired Angiogenesis Following Hindlimb Ischemia in Type 2 Diabetes Mellitus. Differential Regulation of Vascular Endothelial Growth Factor Receptor 1 and Soluble VEGFR-1. Circ Res. 2007, 101: 948-956. 10.1161/CIRCRESAHA.107.160630.CrossRefPubMed
13.
go back to reference Leinonen H, Matikainen E, Juntunen J: Permeability and morphology of skeletal muscle capillaries in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982, 22: 158-162. 10.1007/BF00283744.CrossRefPubMed Leinonen H, Matikainen E, Juntunen J: Permeability and morphology of skeletal muscle capillaries in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1982, 22: 158-162. 10.1007/BF00283744.CrossRefPubMed
14.
go back to reference Wallberg-Henriksson H, Gunnarsson R, Henriksson J, DeFronzo R, Felig P, Ostman J, Wahren J: Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type I diabetics after physical training. Diabetes. 1982, 31: 1044-1050. 10.2337/diabetes.31.12.1044.CrossRefPubMed Wallberg-Henriksson H, Gunnarsson R, Henriksson J, DeFronzo R, Felig P, Ostman J, Wahren J: Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type I diabetics after physical training. Diabetes. 1982, 31: 1044-1050. 10.2337/diabetes.31.12.1044.CrossRefPubMed
15.
go back to reference Henriksson J: Effects of physical training on the metabolism of skeletal muscle. Diabetes Care. 1992, 15: 1701-1711. 10.2337/diacare.15.11.1701.CrossRefPubMed Henriksson J: Effects of physical training on the metabolism of skeletal muscle. Diabetes Care. 1992, 15: 1701-1711. 10.2337/diacare.15.11.1701.CrossRefPubMed
16.
go back to reference Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD: Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol. 1996, 81: 355-361.PubMed Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD: Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol. 1996, 81: 355-361.PubMed
17.
go back to reference Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ: Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol. 1999, 276: H679-85.PubMed Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ: Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol. 1999, 276: H679-85.PubMed
18.
go back to reference Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, Wagner PD: Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol. 1999, 277: H2247-52.PubMed Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, Wagner PD: Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol. 1999, 277: H2247-52.PubMed
19.
go back to reference Tang K, Breen EC, Wagner H, Brutsaert TD, Gassmann M, Wagner PD: HIF and VEGF relationships in response to hypoxia and sciatic nerve stimulation in rat gastrocnemius. Respir Physiol Neurobiol. 2004, 144: 71-80. 10.1016/j.resp.2004.04.009.CrossRefPubMed Tang K, Breen EC, Wagner H, Brutsaert TD, Gassmann M, Wagner PD: HIF and VEGF relationships in response to hypoxia and sciatic nerve stimulation in rat gastrocnemius. Respir Physiol Neurobiol. 2004, 144: 71-80. 10.1016/j.resp.2004.04.009.CrossRefPubMed
20.
go back to reference Hudlicka O, Milkiewicz M, Cotter MA, Brown MD: Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Exp Physiol. 2002, 87: 373-381. 10.1113/eph8702285.CrossRefPubMed Hudlicka O, Milkiewicz M, Cotter MA, Brown MD: Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles. Exp Physiol. 2002, 87: 373-381. 10.1113/eph8702285.CrossRefPubMed
21.
go back to reference Milkiewicz M, Haas TL: Effect of mechanical stretch on HIF-1{alpha} and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol. 2005, 289: H1315-20. 10.1152/ajpheart.00284.2005.CrossRefPubMed Milkiewicz M, Haas TL: Effect of mechanical stretch on HIF-1{alpha} and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol. 2005, 289: H1315-20. 10.1152/ajpheart.00284.2005.CrossRefPubMed
22.
go back to reference Yechoor VK, Patti ME, Saccone R, Kahn CR: Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc Natl Acad Sci USA. 2002, 99: 10587-10592. 10.1073/pnas.142301999.PubMedCentralCrossRefPubMed Yechoor VK, Patti ME, Saccone R, Kahn CR: Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc Natl Acad Sci USA. 2002, 99: 10587-10592. 10.1073/pnas.142301999.PubMedCentralCrossRefPubMed
23.
go back to reference Jemiolo B, Trappe S: Single muscle fiber gene expression in human skeletal muscle: validation of internal control with exercise. Biochem Biophys Res Commun. 2004, 320: 1043-1050. 10.1016/j.bbrc.2004.05.223.CrossRefPubMed Jemiolo B, Trappe S: Single muscle fiber gene expression in human skeletal muscle: validation of internal control with exercise. Biochem Biophys Res Commun. 2004, 320: 1043-1050. 10.1016/j.bbrc.2004.05.223.CrossRefPubMed
24.
go back to reference Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G, Tarnopolsky MA: Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics. 2004, 18: 226-231. 10.1152/physiolgenomics.00067.2004.CrossRefPubMed Mahoney DJ, Carey K, Fu MH, Snow R, Cameron-Smith D, Parise G, Tarnopolsky MA: Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics. 2004, 18: 226-231. 10.1152/physiolgenomics.00067.2004.CrossRefPubMed
25.
go back to reference Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, Hickner RC: Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol. 2004, 96: 19-24. 10.1152/japplphysiol.00748.2003.CrossRefPubMed Gavin TP, Robinson CB, Yeager RC, England JA, Nifong LW, Hickner RC: Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol. 2004, 96: 19-24. 10.1152/japplphysiol.00748.2003.CrossRefPubMed
26.
go back to reference Gustafsson T, Ameln H, Fischer H, Sundberg CJ, Timmons JA, Jansson E: VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. J Appl Physiol. 2005, 98: 2137-2146. 10.1152/japplphysiol.01402.2004.CrossRefPubMed Gustafsson T, Ameln H, Fischer H, Sundberg CJ, Timmons JA, Jansson E: VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. J Appl Physiol. 2005, 98: 2137-2146. 10.1152/japplphysiol.01402.2004.CrossRefPubMed
27.
go back to reference Jensen L, Pilegaard H, Neufer PD, Hellsten Y: Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2004, 287: R397-402.CrossRefPubMed Jensen L, Pilegaard H, Neufer PD, Hellsten Y: Effect of acute exercise and exercise training on VEGF splice variants in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2004, 287: R397-402.CrossRefPubMed
28.
go back to reference Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA. 1996, 93: 2576-2581. 10.1073/pnas.93.6.2576.PubMedCentralCrossRefPubMed Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA. 1996, 93: 2576-2581. 10.1073/pnas.93.6.2576.PubMedCentralCrossRefPubMed
29.
go back to reference Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation. 2002, 105: 373-379. 10.1161/hc0302.102143.CrossRefPubMed Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation. 2002, 105: 373-379. 10.1161/hc0302.102143.CrossRefPubMed
30.
go back to reference Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E, Madeddu P: Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes. 2004, 53: 1096-1103. 10.2337/diabetes.53.4.1096.CrossRefPubMed Emanueli C, Graiani G, Salis MB, Gadau S, Desortes E, Madeddu P: Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. Diabetes. 2004, 53: 1096-1103. 10.2337/diabetes.53.4.1096.CrossRefPubMed
31.
go back to reference Chung AW, Hsiang YN, Matzke LA, McManus BM, van Breemen C, Okon EB: Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature. Circ Res. 2006, 99: 140-148. 10.1161/01.RES.0000232352.90786.fa.CrossRefPubMed Chung AW, Hsiang YN, Matzke LA, McManus BM, van Breemen C, Okon EB: Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature. Circ Res. 2006, 99: 140-148. 10.1161/01.RES.0000232352.90786.fa.CrossRefPubMed
32.
go back to reference Larger E, Marre M, Corvol P, Gasc JM: Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes. 2004, 53: 752-761. 10.2337/diabetes.53.3.752.CrossRefPubMed Larger E, Marre M, Corvol P, Gasc JM: Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes. 2004, 53: 752-761. 10.2337/diabetes.53.3.752.CrossRefPubMed
33.
go back to reference Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, Marra C, Nasti R, Marfella R, Cozzolino D, Indolfi C, Cotrufo M, Torella R, Salvatore T: Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol. 2005, 46: 827-834. 10.1016/j.jacc.2005.06.007.CrossRefPubMed Sasso FC, Torella D, Carbonara O, Ellison GM, Torella M, Scardone M, Marra C, Nasti R, Marfella R, Cozzolino D, Indolfi C, Cotrufo M, Torella R, Salvatore T: Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol. 2005, 46: 827-834. 10.1016/j.jacc.2005.06.007.CrossRefPubMed
34.
go back to reference Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD: Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol. 2000, 88: 1192-1198.PubMed Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD: Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol. 2000, 88: 1192-1198.PubMed
35.
go back to reference Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD: Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise. J Appl Physiol. 2000, 88: 1690-1697.PubMed Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD: Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise. J Appl Physiol. 2000, 88: 1690-1697.PubMed
36.
go back to reference Olfert IM, Breen EC, Mathieu-Costello O, Wagner PD: Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J Appl Physiol. 2001, 90: 1532-1538.PubMed Olfert IM, Breen EC, Mathieu-Costello O, Wagner PD: Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle. J Appl Physiol. 2001, 90: 1532-1538.PubMed
37.
go back to reference Hellsten Y, Nielsen JJ, Lykkesfeldt J, Bruhn M, Silveira L, Pilegaard H, Bangsbo J: Antioxidant supplementation enhances the exercise-induced increase in mitochondrial uncoupling protein 3 and endothelial nitric oxide synthase mRNA content in human skeletal muscle. Free Radic Biol Med. 2007, 43: 353-361. 10.1016/j.freeradbiomed.2007.02.029.CrossRefPubMed Hellsten Y, Nielsen JJ, Lykkesfeldt J, Bruhn M, Silveira L, Pilegaard H, Bangsbo J: Antioxidant supplementation enhances the exercise-induced increase in mitochondrial uncoupling protein 3 and endothelial nitric oxide synthase mRNA content in human skeletal muscle. Free Radic Biol Med. 2007, 43: 353-361. 10.1016/j.freeradbiomed.2007.02.029.CrossRefPubMed
38.
go back to reference Gavin TP, Drew JL, Kubik CJ, Pofahl WE, Hickner RC: Acute resistance exercise increases skeletal muscle angiogenic growth factor expression. Acta Physiol (Oxf). 2007, 191: 139-146.CrossRef Gavin TP, Drew JL, Kubik CJ, Pofahl WE, Hickner RC: Acute resistance exercise increases skeletal muscle angiogenic growth factor expression. Acta Physiol (Oxf). 2007, 191: 139-146.CrossRef
39.
go back to reference Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N: Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 2000, 6: 41-48. 10.1038/71517.CrossRefPubMed Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N: Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med. 2000, 6: 41-48. 10.1038/71517.CrossRefPubMed
40.
go back to reference Stenina OI, Krukovets I, Wang K, Zhou Z, Forudi F, Penn MS, Topol EJ, Plow EF: Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation. 2003, 107: 3209-3215. 10.1161/01.CIR.0000074223.56882.97.CrossRefPubMed Stenina OI, Krukovets I, Wang K, Zhou Z, Forudi F, Penn MS, Topol EJ, Plow EF: Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation. 2003, 107: 3209-3215. 10.1161/01.CIR.0000074223.56882.97.CrossRefPubMed
41.
go back to reference Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI: Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem. 2007, 282: 5704-5714. 10.1074/jbc.M610965200.CrossRefPubMed Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI: Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem. 2007, 282: 5704-5714. 10.1074/jbc.M610965200.CrossRefPubMed
42.
go back to reference Frisbee JC: Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation. 2005, 12: 383-392. 10.1080/10739680590960241.CrossRefPubMed Frisbee JC: Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation. 2005, 12: 383-392. 10.1080/10739680590960241.CrossRefPubMed
43.
go back to reference Olfert IM, Breen EC, Gavin TP, Wagner PD: Temporal thrombospondin-1 mRNA response in skeletal muscle exposed to acute and chronic exercise. Growth Factors. 2006, 24: 253-259. 10.1080/08977190601000111.CrossRefPubMed Olfert IM, Breen EC, Gavin TP, Wagner PD: Temporal thrombospondin-1 mRNA response in skeletal muscle exposed to acute and chronic exercise. Growth Factors. 2006, 24: 253-259. 10.1080/08977190601000111.CrossRefPubMed
44.
go back to reference Brigstock DR: Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis. 2002, 5: 153-165. 10.1023/A:1023823803510.CrossRefPubMed Brigstock DR: Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis. 2002, 5: 153-165. 10.1023/A:1023823803510.CrossRefPubMed
45.
go back to reference Perbal B: CCN proteins: multifunctional signalling regulators. Lancet. 2004, 363: 62-64. 10.1016/S0140-6736(03)15172-0.CrossRefPubMed Perbal B: CCN proteins: multifunctional signalling regulators. Lancet. 2004, 363: 62-64. 10.1016/S0140-6736(03)15172-0.CrossRefPubMed
46.
go back to reference Zhou D, Herrick DJ, Rosenbloom J, Chaqour B: Cyr61 mediates the expression of VEGF, alphav-integrin, and alpha-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells. J Appl Physiol. 2005, 98: 2344-2354. 10.1152/japplphysiol.01093.2004.CrossRefPubMed Zhou D, Herrick DJ, Rosenbloom J, Chaqour B: Cyr61 mediates the expression of VEGF, alphav-integrin, and alpha-actin genes through cytoskeletally based mechanotransduction mechanisms in bladder smooth muscle cells. J Appl Physiol. 2005, 98: 2344-2354. 10.1152/japplphysiol.01093.2004.CrossRefPubMed
47.
go back to reference Hughes JM, Kuiper EJ, Klaassen I, Canning P, Stitt AW, Van Bezu J, Schalkwijk CG, Van Noorden CJ, Schlingemann RO: Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia. 2007, 50: 1089-1098. 10.1007/s00125-007-0621-4.PubMedCentralCrossRefPubMed Hughes JM, Kuiper EJ, Klaassen I, Canning P, Stitt AW, Van Bezu J, Schalkwijk CG, Van Noorden CJ, Schlingemann RO: Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia. 2007, 50: 1089-1098. 10.1007/s00125-007-0621-4.PubMedCentralCrossRefPubMed
48.
go back to reference Birot OJ, Koulmann N, Peinnequin A, Bigard XA: Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J Physiol. 2003, 552: 213-221. 10.1113/jphysiol.2003.043026.PubMedCentralCrossRefPubMed Birot OJ, Koulmann N, Peinnequin A, Bigard XA: Exercise-induced expression of vascular endothelial growth factor mRNA in rat skeletal muscle is dependent on fibre type. J Physiol. 2003, 552: 213-221. 10.1113/jphysiol.2003.043026.PubMedCentralCrossRefPubMed
49.
go back to reference Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML: Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007, 130: 691-703. 10.1016/j.cell.2007.06.054.PubMedCentralCrossRefPubMed Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML: Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007, 130: 691-703. 10.1016/j.cell.2007.06.054.PubMedCentralCrossRefPubMed
50.
go back to reference Rissanen TT, Ylä-Herttuala S: Current status of cardiovascular gene therapy. Mol Ther. 2007, 15: 1233-1247. 10.1038/sj.mt.6300175.CrossRefPubMed Rissanen TT, Ylä-Herttuala S: Current status of cardiovascular gene therapy. Mol Ther. 2007, 15: 1233-1247. 10.1038/sj.mt.6300175.CrossRefPubMed
Metadata
Title
Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice
Authors
Riikka Kivelä
Mika Silvennoinen
Maarit Lehti
Sanni Jalava
Veikko Vihko
Heikki Kainulainen
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2008
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-7-13

Other articles of this Issue 1/2008

Cardiovascular Diabetology 1/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.